Watson Laboratories, a subsidiary of Watson Pharmaceuticals, has won FDA abbreviated new drug application approval for Diclofenac Sodium and Misoprostol Delayed-Release Tablets. The company plans to launch Diclofenac Sodium and ...
Tags: Watson Laboratories
Depomed has attained Zipsor (diclofenac potassium) Liquid Filled Capsule rights from Xanodyne Pharmaceuticals for $25.9m of cash. Depomed acquired the product in return for potential milestone payments based on the sales of Zipsor and ...
Tags: Zipsor Liquid Filled Capsule, Pharmaceuticals, moderate acute pain
Ophthalmologic products provider, InSite Vision has started the patient enrollment for the first Phase 3 clinical trial of BromSite (ISV-303), which is used to reduce pain and inflammation post cataract surgery. The study will enroll ...
Tags: Insite Vision, BromSite Phase 3 Study, Ophthalmologic products
The Scottish Medicines Consortium (SMC) has approved the use of Alcon's Nevanac in patients suffering from diabetes to minimize the possibility of postoperative macular oedema (MO) coupled with cataract surgery. The approval allows the ...
Tags: The Scottish Medicines Consortium, diabetic cataract patients, Medicine
The United States Patent Office has issued a patent covering Nuvo Research's compositions and methods of using Pennsaid (diclofenac sodium topical solution) 2.0% w/w (Pennsaid 2% Patent), which will expire on 21 April 2028. Pennsaid is a ...